Journal article

The use of effect sizes to characterize the nature of cognitive change in psychopharmacological studies: An example with scopolamine

A Fredrickson, PJ Snyder, J Cromer, E Thomas, M Lewis, P Maruff

Human Psychopharmacology | Published : 2008

Abstract

Drug induced cognitive change is generally investigated using small sample sizes. In terms of null hypothesis significance testing (NHST) this can render a meaningful change non-significant, as a result of insufficient power in the statistical model. NHST leads to 'all or none' thinking, where a non-significant result is interpreted as an absence of change. An effect size calculation indicates the magnitude of change which has occurred post-intervention, and therefore whether a significant result is meaningful. We used a scopolamine challenge to demonstrate the usefulness of effect sizes. The aim of the study was to determine how effect sizes could describe the cognitive changes that occur f..

View full abstract

University of Melbourne Researchers